Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Pimavanserin for Irritability in Children and Adolescents With Autism Spectrum Disorder: Phase 2 Randomized Trial.
Journal: Journal of the American Academy of Child and Adolescent Psychiatry
Published: November 18, 2025
Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled Trials.
Journal: Clinical drug investigation
Published: July 13, 2025
Adherence to Background Antipsychotic and Pimavanserin in Patients with Schizophrenia: Post Hoc Analyses from the ENHANCE and ADVANCE Studies.
Journal: Patient preference and adherence
Published: September 14, 2023
Conducting CNS trials during a public health emergency - Lessons learned from the COVID-19 pandemic: A joint ISCTM/ECNP working group consensus paper.
Journal: Neuroscience applied
Published: January 01, 2023
Population Pharmacokinetic Modeling and Stochastic Simulations to Support Pediatric Dose Selection of Pimavanserin.
Journal: Journal of clinical pharmacology
Published: December 21, 2022
Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia: Results From the Phase 2 ADVANCE Study.
Journal: Journal of clinical psychopharmacology
Published: October 03, 2022
Effects of adjunctive pimavanserin and current antipsychotic treatment on QT interval prolongation in patients with schizophrenia.
Journal: Frontiers in psychiatry
Published: March 08, 2022
ENHANCE: Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin for Schizophrenia in Patients With an Inadequate Response to Antipsychotic Treatment.
Journal: Schizophrenia bulletin open
Published: January 08, 2022
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe.
Journal: The lancet. Psychiatry
Published: April 08, 2021
Comorbidities and behavioral issues.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: October 12, 2020
Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme.
Journal: The lancet. Psychiatry
Published: February 29, 2016
Last Updated: 09/26/2026